> Details

Almeida, Luís [Author]; Dhillon-LaBrooy, Ayesha [Author]; Castro, Carla N. [Author]; Adossa, Nigatu [Author]; Carriche, Guilhermina M. [Author]; Guderian, Melanie [Author]; Lippens, Saskia [Author]; Dennerlein, Sven [Author]; Hesse, Christina [Author]; Lambrecht, Bart N. [Author]; Berod, Luciana [Author]; Schauser, Leif [Author]; Blazar, Bruce R. [Author]; Kalesse, Markus [Author]; Müller, Rolf [Author]; Moita, Luís F. [Author]; Sparwasser, Tim [Author]

Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis - [published Version]

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article; Text
  • Title: Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis
  • Contributor: Almeida, Luís [Author]; Dhillon-LaBrooy, Ayesha [Author]; Castro, Carla N. [Author]; Adossa, Nigatu [Author]; Carriche, Guilhermina M. [Author]; Guderian, Melanie [Author]; Lippens, Saskia [Author]; Dennerlein, Sven [Author]; Hesse, Christina [Author]; Lambrecht, Bart N. [Author]; Berod, Luciana [Author]; Schauser, Leif [Author]; Blazar, Bruce R. [Author]; Kalesse, Markus [Author]; Müller, Rolf [Author]; Moita, Luís F. [Author]; Sparwasser, Tim [Author]
  • imprint: [Cambridge, Mass.] : Cell Press, 2020
  • Published in: Immunity 54 (2021), Nr. 1 ; Immunity
  • Issue: published Version
  • Language: English
  • DOI: https://doi.org/10.15488/15728; https://doi.org/10.1016/j.immuni.2020.11.001
  • ISSN: 1074-7613
  • Keywords: mitochondrial translation ; elongation factor G1 ; Argyrin ; autoimmunity ; NAD+ ; ribosome-targeting ; mitochondria ; Linezolid ; antibiotics ; T cells
  • Origination:
  • Footnote: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Description: While antibiotics are intended to specifically target bacteria, most are known to affect host cell physiology. In addition, some antibiotic classes are reported as immunosuppressive for reasons that remain unclear. Here, we show that Linezolid, a ribosomal-targeting antibiotic (RAbo), effectively blocked the course of a T cell-mediated autoimmune disease. Linezolid and other RAbos were strong inhibitors of T helper-17 cell effector function in vitro, showing that this effect was independent of their antibiotic activity. Perturbing mitochondrial translation in differentiating T cells, either with RAbos or through the inhibition of mitochondrial elongation factor G1 (mEF-G1) progressively compromised the integrity of the electron transport chain. Ultimately, this led to deficient oxidative phosphorylation, diminishing nicotinamide adenine dinucleotide concentrations and impairing cytokine production in differentiating T cells. In accordance, mice lacking mEF-G1 in T cells were protected from experimental autoimmune encephalomyelitis, demonstrating that this pathway is crucial in maintaining T cell function and pathogenicity.
  • Access State: Open Access
  • Rights information: Attribution - Non Commercial - No Derivs (CC BY-NC-ND)